MN rgp160 AIDS vaccine: Started Phase I/II trials

Immuno-U.S. Inc. Product: MN rgp160 AIDS vaccine Indication: HIV-positive asymptomatic patients with CD4 counts >500 Status: Started Phase I/II trials in U.S. and Europe ...